Literature DB >> 6408405

(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease.

W Birkmayer, J Knoll, P Riederer, M B Youdim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6408405     DOI： 10.1159/000407513

Source DB:  PubMed          Journal:  Mod Probl Pharmacopsychiatry        ISSN： 0077-0094


× No keyword cloud information.
  15 in total

1.  R-deprenyl: pharmacological spectrum of its activity.

Authors:  K Magyar; B Szende; V Jenei; T Tábi; M Pálfi; E Szöko
Journal:  Neurochem Res       Date:  2010-08-20       Impact factor: 3.996

2.  Restoration and putative protection in Parkinsonism.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 3.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

4.  The effect of selegiline on total scavenger capacity and liver fat content: a preliminary study in an animal model.

Authors:  Gabor Bekesi; Zsolt Tulassay; Gabriella Lengyel; Zsuzsa Schaff; Dezso Szombath; Julia Stark; Istvan Marczell; Peter Nagy-Repas; Ildiko Adler; Elek Dinya; Karoly Racz; Kalman Magyar
Journal:  J Neural Transm (Vienna)       Date:  2011-06-05       Impact factor: 3.575

5.  Basic cell physiological activities (cell adhesion, chemotaxis and proliferation) induced by selegiline and its derivatives in Mono Mac 6 human monocytes.

Authors:  Eszter Lajkó; Lívia Polgár; Orsolya Láng; József Lengyel; László Kőhidai; Kálmán Magyar
Journal:  J Neural Transm (Vienna)       Date:  2011-11-16       Impact factor: 3.575

6.  Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.

Authors:  D E Schmidt; M H Ebert; J C Lynn; W O Whetsell
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.

Authors:  S ThyagaRajan; S K Quadri
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

8.  Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.

Authors:  Orly Weinreb; Tamar Amit; Yotam Sagi; Noam Drigues; Moussa B H Youdim
Journal:  J Neural Transm (Vienna)       Date:  2009-04-25       Impact factor: 3.575

9.  (-)-Deprenyl can induce soluble superoxide dismutase in rat striata.

Authors:  A Clow; T Hussain; V Glover; M Sandler; D T Dexter; M Walker
Journal:  J Neural Transm Gen Sect       Date:  1991

10.  Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.

Authors:  A Fredriksson; T Archer
Journal:  J Neural Transm Gen Sect       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.